Sort
23,748 grants matching “melanoma”
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells
$409,401Anna Karolina Palucka · Baylor Research Institute · R01 · FY2010 · CA
Applying nanosecond pulse electric fields to treat skin cancer
$409,354Richard Lee Nuccitelli · Bioelectromed Corporation · R01 · FY2009 · CA
Applying nanosecond pulse electric fields to treat skin cancer
$409,354Richard Lee Nuccitelli · Bioelectromed Corporation · R01 · FY2010 · CA
Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory
$409,346Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2015 · CA
Immuno-Targeted Therapy for Melanoma
$409,323Antoni Ribas · University Of California Los Angeles · R35 · FY2015 · CA
ELUCIDATION & MODULATION OF NATURAL KILLER CELL SIGNALING: APPLICATION IN CANCER
$409,266Michael A Caligiuri · Ohio State University · P01 · FY2011 · CA
Molecular Interactions During Neural Crest Formation
$409,199Martin Ignacio Garcia-Castro · Yale University · R01 · FY2008 · DE
Indoor Tanning Use, DNA Repair and Risk of Melanoma
$409,158Deann Lazovich · University Of Minnesota · R01 · FY2008 · CA
St.Louis-Cape Girardeau CCOP
$409,001St.Louis-Cape Girardeau Ccop · U10 · FY2002 · CA
REGULATION AND ADAPTIVE MECHANISMS OF ONCOGENIC RAS/ERK SIGNALING
$408,974Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
REGULATION AND ADAPTIVE MECHANISMS OF ONCOGENIC RAS/ERK SIGNALING
$408,974Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Harnessing the potential of pharmacological small molecules to amplify VSV-based oncolytic viral therapy
$408,966Jean Christopher Chamcheu · Southern Univ A&M Col Baton Rouge · R15 · FY2024 · CA
Engineered Ensemble Nanoimmunotherapies for Cancer
$408,831Rohan Fernandes · George Washington University · R37 · FY2021 · CA
PDK1 as a Novel Target in Melanoma
$408,796Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA
Autophagy in Antiviral Immunity
$408,731Akiko Iwasaki · Yale University · R01 · FY2011 · AI
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
$408,718Guangyong Peng · Washington University · R01 · FY2023 · CA
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis
$408,600Florian Karreth · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
A Novel ULK1 Pathway as a New Therapeutic Target in Melanoma
$408,596Diana Nora Vaz Saleiro · Northwestern University At Chicago · R21 · FY2020 · CA
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis
$408,595Florian Karreth · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Role of Perivascular Mesenchymal Stem Cells (pMSCs) in the Bone Marrow Niche and the Extracellular Matrix in the Control of Skeletal Metastasis
$408,530Arnold I. Caplan · Case Western Reserve University · R01 · FY2022 · CA
Mechanics of Cells & Tissues impact Chromosome Instability & Phagocytic Interactions
$408,523Dennis E. Discher · University Of Pennsylvania · P01 · FY2023 · CA
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
$408,419Andrea Facciabene · University Of Pennsylvania · R01 · FY2022 · CA
TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity
$408,401Melanie R Rutkowski · University Of Virginia · R01 · FY2022 · CA
Exosome-Filopodia Interactions
$408,366Alissa M Weaver · Vanderbilt University · R01 · FY2017 · GM
Exosome-Filopodia Interactions
$408,366Alissa M Weaver · Vanderbilt University · R01 · FY2016 · GM